ALS medication AMX0114 has been well tolerated in early clinical testing, and is now moving to a second, higher-dose trial ...
While briefly changing roles with her husband, columnist Kristin Neva got a glimpse of how frustrating it is to have difficulty speaking.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback